Boosting the Immune Response—Combining Local and Immune Therapy for Prostate Cancer Treatment
Due to its slow progression and susceptibility to radical forms of treatment, low-grade PC is associated with high overall survival (OS). With the clinical progression of PC, the therapy is becoming more complex. The immunosuppressive tumor microenvironment (TME) makes PC a difficult target for most...
Main Authors: | Jakub Karwacki, Aleksander Kiełbik, Wojciech Szlasa, Natalia Sauer, Kamil Kowalczyk, Wojciech Krajewski, Jolanta Saczko, Julita Kulbacka, Tomasz Szydełko, Bartosz Małkiewicz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/11/18/2793 |
Similar Items
-
In Vitro Study of Calcium Microsecond Electroporation of Prostate Adenocarcinoma Cells
by: Aleksander Kiełbik, et al.
Published: (2020-11-01) -
Electroporation-Based Treatments in Urology
by: Aleksander Kiełbik, et al.
Published: (2020-08-01) -
Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
by: Dhruv Bansal, et al.
Published: (2021-01-01) -
Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond
by: Sree M. Lanka, et al.
Published: (2023-04-01) -
Long-term complete remission with ipilimumab in metastatic castrate-resistant prostate cancer: case report of two patients
by: Luc Cabel, et al.
Published: (2017-04-01)